JPMorgan Chase & Co. Sells 1,562,303 Shares of Healthcare Realty Trust Incorporated $HR

JPMorgan Chase & Co. lessened its holdings in Healthcare Realty Trust Incorporated (NYSE:HR) by 23.0% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 5,232,512 shares of the real estate investment trust’s stock after selling 1,562,303 shares during the quarter. JPMorgan Chase & Co. owned 1.49% of Healthcare Realty Trust worth $94,342,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Invesco Ltd. raised its stake in Healthcare Realty Trust by 233.8% in the 3rd quarter. Invesco Ltd. now owns 7,700,760 shares of the real estate investment trust’s stock worth $138,845,000 after purchasing an additional 5,393,651 shares in the last quarter. Norges Bank acquired a new position in shares of Healthcare Realty Trust during the 2nd quarter worth approximately $66,085,000. Russell Investments Group Ltd. increased its holdings in shares of Healthcare Realty Trust by 68.7% during the third quarter. Russell Investments Group Ltd. now owns 4,392,815 shares of the real estate investment trust’s stock worth $79,201,000 after purchasing an additional 1,789,111 shares during the period. Rush Island Management LP raised its position in shares of Healthcare Realty Trust by 13.8% in the second quarter. Rush Island Management LP now owns 14,260,152 shares of the real estate investment trust’s stock valued at $226,166,000 after buying an additional 1,728,491 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in shares of Healthcare Realty Trust by 418.3% in the third quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,947,274 shares of the real estate investment trust’s stock valued at $35,109,000 after buying an additional 1,571,583 shares in the last quarter.

Insider Buying and Selling at Healthcare Realty Trust

In other news, Director Thomas N. Bohjalian bought 10,000 shares of the stock in a transaction on Friday, March 6th. The stock was acquired at an average price of $18.09 per share, with a total value of $180,900.00. Following the acquisition, the director directly owned 85,520 shares in the company, valued at approximately $1,547,056.80. This trade represents a 13.24% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.37% of the stock is currently owned by company insiders.

Healthcare Realty Trust Stock Down 0.7%

NYSE:HR opened at $18.03 on Wednesday. Healthcare Realty Trust Incorporated has a twelve month low of $14.09 and a twelve month high of $18.97. The stock’s 50-day simple moving average is $17.61 and its 200 day simple moving average is $17.73. The firm has a market capitalization of $6.29 billion, a PE ratio of -25.39 and a beta of 0.96.

Healthcare Realty Trust (NYSE:HR) last posted its earnings results on Thursday, February 12th. The real estate investment trust reported $0.04 EPS for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.36). The company had revenue of $282.69 million during the quarter, compared to the consensus estimate of $284.37 million. Healthcare Realty Trust had a negative return on equity of 5.07% and a negative net margin of 20.84%.The firm’s revenue was down 7.6% compared to the same quarter last year. During the same period last year, the company posted $0.40 EPS. Healthcare Realty Trust has set its FY 2026 guidance at 1.580-1.640 EPS. On average, analysts anticipate that Healthcare Realty Trust Incorporated will post 1.59 EPS for the current fiscal year.

Healthcare Realty Trust Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 11th. Stockholders of record on Tuesday, February 24th were paid a $0.24 dividend. This represents a $0.96 dividend on an annualized basis and a dividend yield of 5.3%. The ex-dividend date was Tuesday, February 24th. Healthcare Realty Trust’s dividend payout ratio is presently -135.21%.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on HR shares. Cantor Fitzgerald raised their price objective on Healthcare Realty Trust from $19.00 to $21.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 17th. Wells Fargo & Company upped their price objective on shares of Healthcare Realty Trust from $18.00 to $19.00 and gave the stock an “equal weight” rating in a research report on Tuesday, November 25th. Weiss Ratings restated a “hold (c)” rating on shares of Healthcare Realty Trust in a research report on Monday, December 29th. Finally, Wall Street Zen upgraded shares of Healthcare Realty Trust from a “sell” rating to a “hold” rating in a research report on Saturday, January 31st. Three research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $18.88.

Healthcare Realty Trust Company Profile

Healthcare Realty Trust (NYSE: HR) is a real estate investment trust specializing in the ownership, acquisition and management of outpatient medical facilities. Headquartered in Nashville, Tennessee, the company’s portfolio is focused primarily on medical office buildings and outpatient healthcare properties that serve hospitals, health systems and other healthcare providers. Its business model centers on securing long-term, triple-net leases to generate stable income streams from a diversified tenant base.

The company’s properties are located across key metropolitan markets in the United States, including major healthcare hubs in the Southeast, Southwest and in select coastal regions.